Atrial Fibrillation in Acute St-Elevation Myocardial Infarction: Clinical and Prognostic Features
Open Access
- 24 October 2012
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Current Cardiology Reviews
- Vol. 8 (4) , 281-289
Abstract
Atrial fibrillation (AF) is a common arrhythmia in the setting of acute coronary syndrome and acute ST-elevation myocardial infarction (STEMI). This review summarizes recent evidence on the clinical and prognostic significance of pre-existent and new-onset AF in acute STEMI patients and highlights new emerging predictors of AF development in the era of contemporary treatment.Keywords
This publication has 42 references indexed in Scilit:
- B-type natriuretic peptide predicts new-onset atrial fibrillation in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary interventionPeptides, 2012
- Comparison of outcomes of patients with acute coronary syndromes with and without atrial fibrillationThe American Journal of Cardiology, 2003
- Prognostic significance of atrial fibrillation/atrial flutter in patients with acute myocardial infarction treated with percutaneous coronary interventionThe American Journal of Cardiology, 2003
- Significance of Atrial Fibrillation During Acute Myocardial Infarction, and its Current Management: Insights from the GUSTO-3 TrialCardiac Electrophysiology Review, 2003
- Management and outcome of patients with atrial fibrillation during acute myocardial infarction: the GUSTO-III experienceHeart, 2002
- Atrial fibrillation and mortality among patients with acute coronary syndromes without ST-segment elevation: results from the PURSUIT trialThe American Journal of Cardiology, 2001
- Significance of Paroxysmal Atrial Fibrillation Complicating Acute Myocardial Infarction in the Thrombolytic EraCirculation, 1998
- Atrial Fibrillation in the Setting of Acute Myocardial Infarction: The GUSTO-I Experience fn1fn1This study was funded by grants from Genentech, South San Francisco, California; Bayer Corporation, New York, New York; CIBA-Corning, Medfield, Massachusetts; ICI Pharmaceuticals, Wilmington, Delaware; and Sanofi Pharmaceuticals, Paris, France.JACC, 1997
- Early Atrial Arrhythmias in Acute Myocardial InfarctionChest, 1992
- Early atrial fibrillation during evolving myocardial infarction: a consequence of impaired left atrial perfusion.Circulation, 1987